The case for genomic patenting.
Opposition to the patenting of genomic inventions threatens to erode the foundation of intellectual property rights needed to convert innovative research into new drugs, vaccines and diagnostic tests.
SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-5939, USA.
G
G
Poste
D001483:Base Sequence; D016208:Databases, Factual; D030561:Databases, Nucleic Acid; D005060:Europe; D005796:Genes; D036281:Genetic Research; D006801:Humans; D033181:Information Dissemination; D018973:Intellectual Property; D038622:Internationality; D008967:Molecular Biology / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D012106:Research; D012926:Social Control, Formal; D014481:United States